CV Sciences, Inc.
CVSI
$0.0341
-$0.0019-5.28%
| Weiss Ratings | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.39 | |||
| Price History | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 9.65% | |||
| 30-Day Total Return | -14.75% | |||
| 60-Day Total Return | -7.08% | |||
| 90-Day Total Return | -29.11% | |||
| Year to Date Total Return | -2.01% | |||
| 1-Year Total Return | 3.02% | |||
| 2-Year Total Return | -26.19% | |||
| 3-Year Total Return | -69.00% | |||
| 5-Year Total Return | -94.43% | |||
| 52-Week High % Change | -64.53% | |||
| 52-Week Low % Change | 29.96% | |||
| Price | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Dec 12, 2024 | |||
| 52-Week High Price (Date) | Jun 05, 2024 | |||
| Valuation | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.63M | |||
| Enterprise Value | 6.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -422.92% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.42 | |||
| Price/Book (Q) | 3.03 | |||
| Enterprise Value/Revenue (TTM) | 0.42 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -4.91 | |||
| Enterprise Value/EBIT | -4.05 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 182.26M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 866 290 2157 | |||
| Address | 9530 Padgett Street San Diego, CA 92126 | |||
| Website | www.cvsciences.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -10.25% | |||
| Profit Margin | -16.23% | |||
| Management Effectiveness | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -11.10% | |||
| Return on Equity | -- | |||
| Income Statement | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 15.62M | |||
| Total Revenue (TTM) | 15.62M | |||
| Revenue Per Share | $0.09 | |||
| Gross Profit (TTM) | 7.23M | |||
| EBITDA (TTM) | -1.32M | |||
| EBIT (TTM) | -1.60M | |||
| Net Income (TTM) | -2.54M | |||
| Net Income Avl. to Common (TTM) | -2.54M | |||
| Total Revenue Growth (Q YOY) | -5.48% | |||
| Earnings Growth (Q YOY) | -2.01% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 13.79% | |||
| Balance Sheet | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 979.00K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 6.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.19M | |||
| Current Ratio (Q) | 1.098 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 8.39M | |||
| Total Current Liabilities (Q) | 6.14M | |||
| Total Debt (Q) | 835.00K | |||
| Total Liabilities (Q) | 6.20M | |||
| Total Common Equity (Q) | 2.19M | |||
| Cash Flow | CVSI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -162.00K | |||
| Cash from Financing (TTM) | 311.00K | |||
| Net Change in Cash (TTM) | -664.00K | |||
| Levered Free Cash Flow (TTM) | 5.90K | |||
| Cash from Operations (TTM) | -811.00K | |||
